David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
PUT
Centene
CNC
$32.3B
| $2.83M | ﹤0.01% |
80,000
-14,800
| -16% | -$445K |
|
|
GPOR
1752
PUT
DELISTED
Gulfport Energy Corp.
GPOR
| $2.83M | ﹤0.01% |
61,600
-21,000
| -25% | -$888K |
|
|
CTB
1753
DELISTED
Cooper Tire & Rubber Co.
CTB
| $2.81M | ﹤0.01% |
65,694
-31,442
| -32% | -$1.16M |
|
1754
CALL
PVH
PVH
$3.62B
| $2.81M | ﹤0.01% |
26,400
| – | – |
|
|
ENTR
1755
DELISTED
ENTROPIC COMMUNICATIONS INC COM STK (DE)
ENTR
| $2.8M | ﹤0.01% |
946,137
+383,863
| +68% | +$1.08M |
|
|
NBL
1756
DELISTED
Noble Energy, Inc.
NBL
| $2.8M | ﹤0.01% |
57,268
+28,500
| +99% | +$1.33M |
|
1757
Gildan
GIL
$9.92B
| $2.79M | ﹤0.01% |
+94,748
| New | +$2.77M |
|
|
KRA
1758
DELISTED
Kraton Corporation
KRA
| $2.79M | ﹤0.01% |
137,835
+36,239
| +36% | +$716K |
|
|
IRC
1759
DELISTED
INLAND REAL ESTATE CORP
IRC
| $2.79M | ﹤0.01% |
260,477
-113,138
| -30% | -$1.24M |
|
1760
Spire
SR
$4.95B
| $2.78M | ﹤0.01% |
54,289
+5,165
| +11% | +$271K |
|
|
WBK
1761
DELISTED
Westpac Banking Corporation
WBK
| $2.77M | ﹤0.01% |
92,680
+64,200
| +225% | +$1.84M |
|
1762
InterContinental Hotels
IHG
$24.3B
| $2.76M | ﹤0.01% |
53,443
+33,758
| +171% | +$1.78M |
|
|
PACD
1763
DELISTED
Pacific Drilling S A
PACD
| $2.76M | ﹤0.01% |
70,991
-44,280
| -38% | -$1.64M |
|
1764
Tenaris
TS
$27.2B
| $2.76M | ﹤0.01% |
+98,445
| New | +$2.81M |
|
|
UCB
1765
United Community Banks
UCB
$4.25B
| $2.76M | ﹤0.01% |
145,982
+5,905
| +4% | +$109K |
|
1766
CALL
Incyte
INCY
$26B
| $2.75M | ﹤0.01% |
30,000
-17,400
| -37% | -$1.44M |
|
1767
CALL
Fluor
FLR
$6.96B
| $2.75M | ﹤0.01% |
48,100
-43,700
| -48% | -$2.48M |
|
|
JWN
1768
CALL
DELISTED
Nordstrom
JWN
| $2.75M | ﹤0.01% |
34,200
| – | – |
|
1769
Cigna
CI
$74.2B
| $2.73M | ﹤0.01% |
21,120
-89,307
| -81% | -$10.4M |
|
1770
Minerals Technologies
MTX
$2.24B
| $2.73M | ﹤0.01% |
37,398
+31,862
| +576% | +$2.16M |
|
1771
PUT
Dillards
DDS
$9.87B
| $2.73M | ﹤0.01% |
20,000
-16,200
| -45% | -$2.02M |
|
|
TEN
1772
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $2.72M | ﹤0.01% |
+47,435
| New | +$2.63M |
|
|
SRGA
1773
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $2.72M | ﹤0.01% |
18,357
+1,241
| +7% | +$189K |
|
1774
CALL
Alcoa
AA
$13.1B
| $2.71M | ﹤0.01% |
87,391
-632,709
| -88% | -$22.7M |
|
|
NJ
1775
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
| $2.7M | ﹤0.01% |
161,722
+54,007
| +50% | +$906K |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.